Cyclin B1 overexpression and resistance to radiotherapy in head and neck squamous cell carcinoma

Cancer Research

Volumn 62, Issue 22, 2002, Pages 6414-6417

  Hassan, Khaled A ^a   Ang, K Kian ^a   El Naggar, Adel K ^a   Story, Michael D ^a   Lee, Janet I ^a   Liu, Diane ^a   Hong, Waun K ^a   Mao, Li ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1;

ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; HEAD AND NECK CANCER; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CYCLIN B; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTICENTER STUDIES; PROSPECTIVE STUDIES; RADIATION TOLERANCE; RANDOMIZED CONTROLLED TRIALS;

EID: 0037112518     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Vokes, E. E., Weichselbaum, R. R., Lippman, S. M., and Hong, W. K. Head and neck cancer, N. Engl. J. Med., 328: 184-194, 1993.
2. Gallo, O., Chiarelli, I., Boddi, V., Bocciolini, C., Bruschini, L., and Porfirio, B. Cumulative prognostic value of p53 mutations and bcl-2 protein expression in head-and-neck cancer treated by radiotherapy. Int. J. Cancer, 84: 573-579, 1999.
3. Weichselbaum, R. R. Beckett, M. A. Schwartz, J. L., and Dritschilo, A. Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 15: 575-579, 1988
4. Gath, H. J., and Brakenhoff, R. H. Minimal residual disease in head and neck cancer. Cancer Metastasis Rev., 18: 109-126, 1999.
5. Greenlee, R. T., Hill-Harmon, M. B., Murray, T., and Thun, M. Cancer statistics, 2001. CA Cancer J. Clin., 51: 15-37, 2001.
6. Loree, T. R., and Strong, E. W. Significance of positive margins in oral cavity squamous carcinoma. Am. J. Surg., 160: 410-414, 1990.
7. Farr, H. W., and Arthur, K. Epidermoid carcinoma of the mouth and pharynx. J. Laryngol. Otol., 86: 243-253, 1972.
8. Looser, K. G., Shah, J. P., and Strong, E. W. The significance of "positive" margins in surgically resected epidermoid carcinomas. Head Neck Surg., 1: 107-111, 1978.
9. Carter, R. L., Tanner, N. S., Clifford, P., and Shaw, H. J. Perineural spread in squamous cell carcinomas of the head and neck: A clinicopathological study. Clin. Otolaryngol, 4: 271-281, 197.
10. Shah, J. P., Cendon, R. A., Farr, H. W. and Strong, E. W. Carcinoma of the oral cavity, factors affecting treatment failure at the primary site and neck. Am. J. Surg., 132: 504-507, 1976.
11. Johnson, J. T. Turner, J., Dekker, A., and Myers, E. N. Significance of positive bronchial cytology in presence of squamous cell carcinoma of upper aerodigestive tract. Ann. Otol. Rhinol. Laryngol., 90: 454-456, 1981.
12. Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., Morrison, W. H., Weber, R. S., Garden, A. S., and Frankenthaler, R. A. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int. J. Radiat. Oncol. Biol. Phys., 26: 3-11, 1993.
13. Gatenby, R. A., Kessler, H. B., Rosenblum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., and Broder, G. J. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int. J. Rad. Oncol. Biol. Phys., 14: 831-838, 1988.
14. Weichselbaum, R. R. Dahlberg, W., and Little, J. B. Inherently radioresistant cells exist in some human tumors. Proc. Nat. Acad. Sci. USA, 82: 4732-4735, 1985.
15. Steele, G. C., Adams, G. E., and Peckam, M. J. The Biological Basis of Radiotherapy. New York: Elsevier, pp. 1-25, 1983.
16. Norbury, C., and Nurse, P. Animal cell cycles and their control. Annu. Rev. Biochem., 61: 441-470, 1992.
17. Li, J., Meyer, A. N., and Donoghue, D. J. Nuclear localization of cyclin B1 mediates its biological activity and is regulated by phosphorylation. Proc. Nat. Acad. Sci. USA, 94: 502-507, 1997.
18. Pines, J., and Hunter, T. The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in Cyclin B. EMBO J., 13: 3772-3781, 1994.
19. Hassan, K. A., El-Naggar, A. K., Soria, J. C., Liu, D., Hong, W. K., and Mao, L. Clinical significance of cyclin BI protein expression in squamous cell carcinoma of the tongue. Clin. Cancer. Res., 7: 2458-2462, 2001.
20. Murakami, H., Furihata, M., Ohtusi, Y., and Ogoshi, S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch., 434: 153-158, 1999.
21. Ang, K. K., Trotti, A., Brown, B. W., Garden, A. S., Foote, R. L., Morrison, W. H., Geara, F. B., Klotch, D. W. Goepfert, H., and Peters, L. J. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 51: 571-578, 2001.
22. Smith, B. D., and Haffty, B. G. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. Radiat. Oncol. Investig., 7: 125-144, 1999.
23. Salesiotis, A. N., and Cullen, K. J. Molecular markers predictive of response and prognosis in the patient with advanced squamous cell carcinoma of the head and neck: Evolution of a model beyond TNM staging. Curr. Opin. Oncol., 12: 229-239, 2000.
24. Quon, H., Liu, F. F., and Cummings, B. J. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck, 23: 147-159, 2001.
25. De Souza, C. P., Ellem, K. A., and Gabrielli, B. G. Centrosomal and cytoplasmic Cdc2/cyclin BI activation precedes nuclear mitotic events. Exp. Cell Res., 257: 11-21, 2000.
26. 2 arrest in response to overexpression of p53. Mol. Biol. Cell, 10: 3607-3622, 1999.
27. Innocente, S. A., Abrahamson, J. L., Cogswell, J. P., and Lee, J. M. p53 regulates a G2 checkpoint through cyclin B1. Proc. Natl. Acad. Sci. USA, 96: 2147-2152, 1999.
28. Park, M., Chae, H. D., Yun, J., Jung, M., Kim, Y. S., Kim, S. H., Han, M. H., and Shin, D. Y. Constitutive activation of cyclin B1-associated cdc2 kinase overrides p53-mediated G2-M arrest. Cancer Res., 60: 542-545, 2000.